GU Cancers 2024 | Predicting pelvic lymph node involvement in MIBC with FDG-PET

Antonio Cigliola, MD, IRCCS San Raffaele Hospital, Milan, Italy, gives an overview of utilizing fluoro-deoxy-glucose positron emission tomography (FDG-PET) to predict pelvic lymph node involvement (LNI) in patients with muscle-invasive bladder cancer (MIBC). Whilst a number of patients who were FDG-PET positive had T3-T4 bladder cancer, FDG-PET was not found to be efficacious as CT scans in patients with variant histologies. This interview took place at the ASCO GU Cancers Symposium 2024 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.